The Point of View of Hematological Cancer Patients and Their Loved Ones Regarding Spirituality

Hematologic Cancer Clinical Trial

— SPIRIHEMATO  

Official title:

The Point of View of Hematological Cancer Patients and Their Loved Ones Regarding Spirituality During the Initial Healing Phase

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT04412135
• Other study ID #: 87RI19_0050
• Status: Not yet recruiting
• Start date: June 2020
• Est. completion date: June 2021

Study information

• Verified date: March 2020
• Source: University Hospital, Limoges
• Contact: Jean TONIOLO
• Phone: +33 5 55 05 67 55
• Email: jean.toniolo[@]chu-limoges.fr
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The management of patients with malignant hemopathy is based on comprehensive management. In this context and faced with the various difficulties encountered by cancer patients, the question of spirituality and its experience is central. Spirituality refers to the person's attachment to what inspires and gives him foundation, as well as the beliefs, values, and existential experiences associated with it, whether these are religious in nature or not. Although the concept has been identified as a resource in the literature and widely treated in an end-of-life context, assessing the needs of patients with hematological cancer and their loved ones in terms of spirituality from the initiation of treatment does not has not been developed

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 10
• Est. completion date: June 2021
• Est. primary completion date: February 2021
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Aged = 18 years with a recent diagnosis of hematological cancer (lymphoma or leukemia) and in treatment;

• Patients who speak and read French;

• Patients in general condition (physical and mental) judged emotionally and physically fit by the referring nurse to answer the questionnaires;

• Patients benefiting from a social security scheme,

• Patients who signed the non-objection form after being informed of the study,

family person:

• Have been designated by the patient as being the loved one they wish to include with them;

• Aged = 18 years;

• Fluent in and reading French;

• Having signed the non-objection form after being informed of the study.

Exclusion Criteria:

• Patients in recurrence / progress or in remission of cancer;

• Patients in the terminal phase of the disease.

Family person:

person in the curative phase of cancer

Related Conditions & MeSH terms

• Hematologic Cancer
• Hematologic Neoplasms

Intervention

Other:
• spirituality
Patients will take three questionnaires (FACIT-Sp, Euroqol 5 dimensions and ESAS)

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital, Limoges

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	FACIT-Sp questionnaire		15 minutes